SOLICITATION NOTICE
66 -- Multi-Purpose Tissue Clearing System for clearing rodent whole-brain samples using a stochastic electric field - Invoice Instructions & Commercial Clauses
- Notice Date
- 8/24/2018
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211, MSC 9559, Bethesda, Maryland, 20892-9559, United States
- ZIP Code
- 20892-9559
- Solicitation Number
- NIHDA201800359
- Archive Date
- 9/14/2018
- Point of Contact
- Joshua T. Lazarus, Phone: 3014436677, Andrew Hotaling, Phone: 301-443-6677
- E-Mail Address
-
josh.lazarus@nih.gov, andrew.hotaling@nih.gov
(josh.lazarus@nih.gov, andrew.hotaling@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Invoice Instructions & Commercial Clauses Description: This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a separate written solicitation will not be issued. This solicitation is issued as a Request for Quotation (RFQ) on a Full and Open basis, through competitive brand name or equal, open market, commercial procedures. A fixed price purchase order is contemplated for this requirement. This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures; and FAR Part 12-Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. A fixed-price type of purchase order is contemplated for this requirement. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-88-1 / 06-15-2016. The North American Industry Classification System (NAICS) code for this procurement is 334516 -Analytical Laboratory Instrument Manufacturing with associated small business size standard of 1,000 employees. Purchase Description Background: The National Institute on Drug Abuse (NIDA) Histology Core serves the NIDA Intramural Research Program (IRP) researchers by providing access to existing and emerging neuroanatomical technologies. The NIDA Histology Core offers the following services: (1) histology services that are tailored to the needs of individual IRP researchers. Services include sectioning, immunostaining and counterstaining, whole-brain serial tomography, and imaging of cleared sample using light-sheet microscopy; and (2) training and access to different types of microscopes, 2 cryostats, one vibratome, and computers for image analysis. NIDA is expanding service for whole-brain clearing and immunohistochemistry and needs an automatize system for tissue clearing and immunostaining. Equipment for clearing and immunostaining samples are commercially available providing an option for expedite tissue processing and handling several samples simultaneously. By acquiring an automatize system, NIDA Histology Core will be able to offer a service to the IRP to aid their interests on studying intact circuits in whole-brains of mice and rodents. Samples prepared on the system will be imaged in NIDAs light-sheet microscope. Requirement: IRP requires a SmartClear II Pro System (brand name) or equal Multi-Purpose Tissue Clearing and Immunostaining System for clearing and immunostaining rodent whole-brain samples with the following requirements as well as the additional components as described below: Salient Characteristics: Prospective products must have the following characteristics: 1. The equipment should use a stochastic electric field for clearing whole-brain mouse or rat samples. 2. The equipment should use a stochastic electric field for the aid of antibody penetration. 3. The equipment should be able to clear a single sample and batch process multiple whole-brain mouse or rat samples to remove fats while keeping protein on tissue for immunohistochemistry. 4. The equipment should come with sample holders and necessary buffers solution to be run for at least 3 months. 5. Full warranty to include twelve months full parts and labor. Additional Product Details: In addition to the Multi-Purpose Tissue Clearing and Immunostaining System capable sources must be able to provide the following product accessories: Description Quantity - Reagents: One Month Clearing Buffer Kit (up to 3 Buffer Sets (A, B) and 3 Membrane Pairs) 4 - Reagents: Optical Clearing Solution (500mL), RI=1.46 1 - Reagents: Optical Clearing Solution (100mL), RI=1.46 1 Anticipated Delivery Date: The equipment shall be delivered within 60 days after contractor receipt of order. Deliverables and Reporting requirements All deliverables required under this purchase order shall be packaged, marked and shipped in accordance with Government specifications. All items shall be packaged in crates suitable for international shipping. The Contractor shall guarantee that all required materials shall be delivered in immediate usable and acceptable condition. All equipment must be delivered to: Carlos Mejias-Aponte National Institute on Drug Abuse 251 Bayview Boulevard, Suite 200 BRC, Rm. 08A Baltimore, MD 21224. All packaging shall be marked with the name, Carlos Mejias-Aponte, National Institute on Drug Abuse, NIDA-IRP, and the purchaser order number. Submission Instructions: All responses to this solicitation must be submitted electronically to the Contract Specialist and Contracting Officer Identified below. The response must be received on or before August 30, 2018 at 4:00 p.m. EST. Facsimile responses are NOT accepted. One (1) copy of the quote is required and must be in Microsoft Word or Adobe PDF format. The information submitted must be must be in and outline format that addresses each of the elements of the requirement and in the capability statement /information sought paragraphs stated herein. A cover page and an executive summary may be included but is not required. The response is limited to ten (10) page limit. The 10-page limit does not include the cover page, executive summary, or references, if requested. Responses to this solicitation must include sufficient information to establish the interested parties' bona-fide capabilities of providing the product or service. Responses to this solicitation must include clear and convincing evidence of the Offeror's capability of fulfilling the requirement as it relates to the government requirements stated in this solicitation. The Offeror's technical approach shall indicate compliance with the Scope of Work, and describe an essential understanding of the requirements involved in accomplishing the work. Basic cost and price information in the Offerors business proposal must contain sufficient information to allow the Government to perform a basic analysis of the reasonableness of the Offeror to supply the required services. Any other information or factors that may be considered in the award decision may include such factors as: past performance; special features required for effective service coverage; trade-in considerations; warranty considerations; maintenance and service coverage availability; serial, product or catalog number(s); product description; delivery terms, and prompt payment discount terms. Respondents that believe that they are manufacturers or authorized resellers of the brand-name or equal product as specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order. Offerors MUST include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications Commercial Items, with their offer, OR provide a copy of the valid certifications registrations and Representation and Certifications from the System of Award Management (SAM) applications at www.SAM.gov, which may be indicated on the Offeror's cover sheet. In addition, the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All Offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." The response must include the respondents' technical and administrative points of contact (including names, titles, addresses, telephone and fax numbers, and e-mail addresses) and DUNS number. Disclaimer and Important Notes: This solicitation does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Publications and Publicity: Contractor shall not, nor is required to, publish any articles of data as a result of fulfilling this requirement Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s)." Invoice Submission Instructions: Invoice Instruction for NIH Fixed-Price Type Contracts are as follows. The invoice instructions and the following directions for the submission of invoices must be followed to meet the requirement of a "proper" invoice, pursuant to FAR 32.9: (1) Payment requests shall be submitted as follows: (a) One original to the following designated billing office: National Institutes of Health Office of Financial Management Commercial Accounts 2115 East Jefferson Street, Room 4B-432, MSC 8500 Bethesda, MD 20892-8500 (b) One copy to the following approving official: Carol Lindsay (c) The Contractor shall submit an electronic copy of the payment request to the COR in lieu of a paper copy. The payment request shall be transmitted as an attachment via e-mail to the address listed above in a format compatible with the computer systems at NIH [e.g., MS Word, MS Excel, or Adobe Portable Document Format (PDF)]. (Note: The original payment request must still be submitted in hard copy and mailed to the designated billing office to meet the requirements of a "proper invoice.")] (2) In addition to the requirements specified in FAR Subpart 32.9 for a proper invoice, the Contractor shall include the following information on all payment requests: (a) Name of the Office of Acquisitions. The Office of Acquisitions for this contract is NIDA. (b) Central Point of Distribution. For the purpose of this contract, the Central Point of Distribution is not applicable. (c) Vendor Identification Number. This is the 7-digit number that appears after the Contractor's name in Block 7.a. of Optional Form 347. (d) DUNS number or DUNS+4 that identifies the Contractor's name and address exactly as stated on the face page of the contract. (e) Identification of whether payment is to be made using a two-way or three-way match. This contract requires a three-way match. (3) Inquiries regarding payment of invoices should be directed to the designated billing office, (301) 496-6088. All NIH contracts are expressed in United States dollars. Where expenditures are made in a currency other than United States dollars, billings on the contract shall be expressed, and reimbursement by the United States Government shall be made, in that other currency at amounts coincident with actual costs incurred. Currency fluctuations may not be a basis of gain or loss to the Contractor. Notwithstanding the above, the total of all invoices paid under this contract may not exceed the United States dollars authorized. For additional information please see the attachment. Additional Terms and Conditions, Provisions, and Representations: The FAR Clauses are incorporated by reference and are provided in full text at https://www.acquisition.gov/ 1. The provisions of FAR Clause 52.212-1 Instructions to Offerors-Commercial Items (JAN 2017) is applicable to this solicitation. 2. The provisions of FAR Clause 52.212.2 Evaluation-Commercial Items (Oct 2014) is applicable to this solicitation. Lowest price technically acceptable (LPTA) approach will be used to evaluate quotes. 3. The provisions of FAR Clause 52.212-3, Offeror Representations and Certifications-Commercial Items (JAN 2017), is applicable to this solicitation. 4. The provisions of FAR Clause 52.212-4, Contract Terms and Conditions-Commercial Items (JAN 2017) with Addenda: Stop Work Order, FAR Clause 52.242-15 (August 1989) is applicable to this solicitation. 5. The provisions of FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items (JAN 2017) is applicable to this solicitation. See the attachment for additional details. The provision at FAR clause 52.212-2, Evaluation - Commercial Items, applies to this acquisition. The following is provided as an addendum to clause 52.212-2: (a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government. This RFQ will be evaluated on the basis of LPTA. Offeror's submitting a response must provide a completed Price Quote to be evaluated and considered for award. Price quotes must indicate fixed unit pricing and total cost, including shipping cost and estimated time of delivery after receipt of order, and warranty and training considerations. Under the lowest-price technically acceptable LPTA process, Offerors' will be determined to be "technically acceptable" or "technically unacceptable" based on an evaluation of responses against the following factors to determine if, as submitted, the proposal is technically acceptable. Award will be made to the lowest-priced, technically acceptable, responsible offeror. Technical acceptability shall be based on the following: 1. The Offeror must indicate in its quotation the ability to provide all the salient characteristics as identified above in the requirements. 2. The Offeror must indicate in its quotation the ability to meet the delivery requirements. A written notice of award or acceptance of an offer transmitted or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer's specified expiration time, the Government may accept an offer (or part of an offer), if there are negotiations after its receipt, unless a written notice of withdrawal is received before award. Responses to this solicitation must include clear and convincing evidence of the Offeror's capability of fulfilling the requirement as it relates to the technical evaluation criteria. Offerors may respond with a proposal indicating their ability to provide the technical specifications stated in this solicitation. Responses will be evaluated based on the contractor's ability to meet the government's requirements stated in this notice and on ability to deliver required services and supplies. There are no additional contract requirement(s) or terms and conditions applicable to this acquisition. The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/NIHDA201800359/listing.html)
- Place of Performance
- Address: National Institute on Drug Abuse, 251 Bayview Boulevard, Suite 200, BRC, Rm. 08A, Baltimore, Maryland, 2122, United States
- Record
- SN05054723-W 20180826/180824230815-a3d1f43eb6fd80577e95338e6ae66a40 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |